ErleneKuizonSeymourMD

Oncology • New York, NY

Hematologic Oncology

Medical Director

Join to view full profile

Dr. Seymour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seymour's full profile

Already have an account?

Office
233 Spring St
New York, NY 10013

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2013 - 2016
University of MichiganResidency, Internal Medicine, 2008 - 2011
Wayne State University School of MedicineClass of 2008, MD

Certifications & Licensure

MI State Medical License 2011 - 2027
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
ACTIVE_NOT_RECRUITING
PHASE2
Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma Start of enrollment: 2017 Jun 20
Recruiting
Phase 1, Phase 2
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma Start of enrollment: 2020 Aug 17
Suspended
Phase 1, Phase 2
Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) Start of enrollment: 2020 Nov 18
Suspended
Phase 1, Phase 2
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) Start of enrollment: 2016 Jun 17
COMPLETED
PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase...
Pau Abrisqueta, Eva González-Barca, Carlos Panizo, José María Arguiñano Pérez, Fiona Miall
The Lancet. Haematology. 2024-02-01
5 citations
The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021.
Gaurav Goyal, Krystal W Lau, Xiaoliang Wang, Amy J Davidoff, Scott F Huntington
JAMA Network Open. 2023-06-01
2 citations
Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in...
Gaurav Goyal, Tylan Magnusson, Xiaoliang Wang, James Roose, Mayur Narkhede
Haematologica. 2023-04-01

Abstracts/Posters

A Multicenter Study of Ibrutinib Resistance Development and Intervention with Venetoclax in Patients with Chronic Lymphocytic Leukemia
Erlene K. Seymour, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

OncLive® Presents the Latest State of the Science Summit™ on Hematologic MalignanciesSeptember 5th, 2018